Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage

Date
2006
Author
AL-MARRI, A.
Bener, Abdulbari
MORAD, N.
YAKOOB, R.
AMER, A. M.
DERBALA, M. F.
AL KAABI, S. R.
EL DWEIK, N. Z.
PASIC, F.
BUTT, M. T.
Metadata
Show full item record
Abstract
AIM: To evaluate pegylated interferon alpha2a (PegIFN-alpha 2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate.
URI
http://hdl.handle.net/20.500.12627/44820
https://doi.org/10.3748/wjg.v12.i35.5692
Collections